Impact of a Prebiotic Food-enriched Diet (PreFED) in Combination With Ipilimumab/Nivolumab Combination Immune Checkpoint Blockade (ICB) in ICB-refractory Melanoma Patients
Clinical trial NCT06250335 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06250335
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2027-01-23
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.